Work

Efficacy and Safety of CX-8998 in T-CALM, a Randomized, Double-Blind, Placebo-Controlled, Phase 2a Trial in Participants With Essential Tremor: Subgroup Analysis by Baseline Tremor Severity (1842)

Year: 2020

Type: article

Source: Neurology

DOI: 10.1212/wnl.94.15_supplement.1842

Authors: Hyder A. Jinnah, Spyros Papapetropoulos, Margaret Lee, Stacey Boyer, Evan Newbold, Rajesh Pahwa, Kelly E. Lyons, Rodger Elble, William Ondo, Theresa Zesiewicz, Peter Hedera, Adrian Handforth, Jenna Elder, Mark Versavel

Institutions: Emory University, Massachusetts General Hospital, Jazz Pharmaceuticals (United States), Cerevel Therapeutics (United States), University of Kansas Medical Center, Southern Illinois University Carbondale, SIU Medicine, Houston Methodist, University of South Florida, Vanderbilt University, VA Greater Los Angeles Healthcare System

Language: English

Topic: Neurological disorders and treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4389447624

FWCI: 0.108

Cites:

Cited by: 1

Related to: 10